Amelioration of muscle wasting by glucagon‐like peptide‐1 receptor agonist in muscle atrophy
Abstract Background Skeletal muscle atrophy is defined as a reduction of muscle mass caused by excessive protein degradation. However, the development of therapeutic interventions is still in an early stage. Although glucagon‐like peptide‐1 receptor (GLP‐1R) agonists, such as exendin‐4 (Ex‐4) and du...
Tallennettuna:
| Päätekijät: | , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Wiley
2019-08-01
|
| Sarja: | Journal of Cachexia, Sarcopenia and Muscle |
| Aiheet: | |
| Linkit: | https://doi.org/10.1002/jcsm.12434 |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|